Cargando…

Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis

BACKGROUND: Influenza is a common viral respiratory infection that causes epidemics and pandemics in the human population. Oseltamivir is a neuraminidase inhibitor—a new class of antiviral therapy for influenza. Although its efficacy and safety have been established, there is uncertainty regarding w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Kunling, Xiong, Tengbin, Tan, Seng Chuen, Wu, Jiuhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833415/ https://www.ncbi.nlm.nih.gov/pubmed/27082431 http://dx.doi.org/10.1371/journal.pone.0153664

Ejemplares similares

Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015–2016
por: Hamdan, Lubna, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
por: Moreno, Gerard, et al.
Publicado: (2021)

Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support
por: Wildschut, Enno D., et al.
Publicado: (2010)

922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States
por: Hansen, Svenn, et al.
Publicado: (2023)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC(4)E trial in 15 European countries
por: Li, Xiao, et al.
Publicado: (2022)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

Maternal and Perinatal Outcomes of Influenza in Pregnancy after Treatment with Oseltamivir
por: Abraham, Kavitha, et al.
Publicado: (2021)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
por: Honce, Rebekah, et al.
Publicado: (2023)

Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial
por: Li, Xiao, et al.
Publicado: (2021)

Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis
por: Hernu, Romain, et al.
Publicado: (2017)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Rate of use and effectiveness of oseltamivir in the treatment of influenza illness in high‐risk populations: A systematic review and meta‐analysis
por: Shim, So‐Jung, et al.
Publicado: (2021)

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
por: Men, Peng, et al.
Publicado: (2018)

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
por: Davies, Brian E.
Publicado: (2010)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children
por: Reisinger, Keith, et al.
Publicado: (2012)

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
por: Lee, Jin Seo, et al.
Publicado: (2020)

Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
por: Hooker, Kyla L., et al.
Publicado: (2021)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
por: Dronavalli, Mithilesh, et al.
Publicado: (2020)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China
por: Qin, Shukui, et al.
Publicado: (2018)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season
por: Coleman, Brenda L., et al.
Publicado: (2011)

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
por: Jefferson, Tom, et al.
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
por: Bautista, Francisco, et al.
Publicado: (2019)

Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome
por: Hanshaoworakul, Wanna, et al.
Publicado: (2009)

Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia
por: Kositpantawong, Narongdet, et al.
Publicado: (2021)

Oseltamivir Treatment for Influenza During the Flu Season of 2018–2019: A Longitudinal Study
por: Li, Xiao-Guang, et al.
Publicado: (2022)

Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis
por: Harbin, Nicolay Jonassen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72m8d96q7ung93u3p1ugmeoavf